+44 (0) 1223 755950
+1 832 327 7413
Orders to United States ship from United States
| Target | Vimentin (VIME) |
| Research Area | Tumor Immunity, Developmental Science, Cancer |
| Clonality | Monoclonal |
| Reactivity | Human |
| Tested Applications | WB, IHC, IF/ICC |
| Host | Mouse |
| Recommended dilutions | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Immunogen | Recombinant Vimentin (VIM) (Ser2-Glu466) expressed in E. coli. |
| Isotype | IgG2a Kappa |
| Form | Liquid |
| Purification | Purified by Protein A and Protein G affinity chromatography. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Shelf Life | 24 months. |
| UniProt Primary AC | P08670 (UniProt, ExPASy) |
| UniProt Entry Name | VIME_HUMAN |
| KEGG | hsa:7431 |
| String | 9606.ENSP00000446007 |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |